X
CONTACT US

CONTACT US

Please complete this short form to get in touch with a member of our team and we will get back to you as soon as we can.

X
NEWSLETTER

NEWSLETTER

Sign up to our newsletter by completing the form below.

We use cookies.

To make your experience the best it can be, we use cookies and similar technologies on our site. We need your permission to allow these technologies, which will maximise browsing experience. For more information on how we use cookies and how to change your cookie settings, please see our cookies and privacy policy.

Header image for the current page SPI - Support for the Life Sciences sector

Support for the Life Sciences sector

Share this page

Life science organisations play a crucial role in providing the NHS with medical research and driving the development of new treatments and technologies that enhance patient care and outcomes.

However, for many life science organisations, navigating the complexities of NHS markets can be a constant challenge. Lengthy procurement processes, stringent regulatory requirements and ever-growing financial constraints can make getting your life-changing products into the hands of patients a difficult task. Additionally, the fragmented nature of the NHS landscape means that understanding where there is a demand for your products and in which areas they can make the biggest positive impact on patients also requires specialist knowledge and in-depth research.

We partner with the life sciences sector to support your objectives by understanding how improved adoption of tools, technology and medicines in the NHS will enable both industry growth and value for the NHS. We seek to contribute at every level to improve health outcomes at patient, system and population level.

NHS Arden & GEM works with over 80 organisations across the health and care system including NHS England, local commissioners, provider trusts and primary care.

As part of the NHS fabric, but with commercial focus, we fully understand national policy and how this translates to operational delivery, system requirements and the day-to-day challenges across the system. Our expertise spans specialised and broader health commissioning and our service offer can support your business objectives throughout the product lifecycle.

As a trusted supplier of thousands of core services across the NHS, we fully understand national policy, operational delivery challenges and the importance of clinical engagement. Our work with life science partners provides expert NHS insight and perspective to support product innovation, access, and wider enablers that can deliver value and efficiency. We can help you to accelerate the adoption of tools, technology and medicines in the NHS to improve health outcomes.

We deliver support to the life sciences sector in eight key domains:

  • Effective, seamless business intelligence services including capacity demand modelling, tariff road-testing, QIPP planning, advanced analytics and population health giving you all the data you need to commission and manage services
  • Nationally recognised data processing capabilities with robust processes in place to manage data access. Arden & GEM is an authorised DSCRO and we host and process data on behalf of ICBs and NHS England
  • Management and access to Secure Data Environments (SDEs) for data and research analysis
  • Flexible and proactive resources to ensure you benefit from both local expertise and best practice. Our hub and spoke delivery model provides embedded analysts within client teams and expert analysts in our local and central intelligence hubs.

Our multi award winning NHS data analysts provide economic evaluations that can help you to identify the best value healthcare interventions and care pathways.

Our unrivalled access to data and specialist health analysis ensures we are ideally placed to support your needs. Services include:

  • Budget impact analysis to establish a clear understanding of the cost of adopting new technologies and interventions
  • Patient flow and care pathway modelling for detailed insight and helping to improve how patients move through different stages of their care
  • Event simulation to test changes and see their effects without disrupting real world operations
  • NICE appraisals to understand whether interventions are effective, efficient, and deliver value for money.

From discovery to implementation and evaluation, our experienced team of health and care transformation experts deliver clinical service redesign support throughout the change lifecycle. Our support includes:

  • Business case development for capital and service development - including primary care business cases and transaction
  • System development including strategic document authorship, target operating model development and place development
  • Public health expertise including evaluation and advice on specialised service interventions
  • Project, programme and portfolio management expertise.

We provide seasoned executive level system leaders to support your strategy, operational delivery and market engagement teams.

We can also build bespoke training and insights to support your teams in market access opportunities. Examples of this, includes principles of NHS business case development and introductory level navigation of Specialised Commissioning.

Our high calibre, trusted and skilled resource can deliver both expertise and credibility to your approach, ensuring you align with the needs of the market and maximise the opportunity for success.

Our specialist social value expertise enables life science organisations to create, refine and execute Green Plans, implement net zero and sustainability strategies that align with the requirements of the NHS.

As one of only a handful of organisations to achieve Social Value Quality Mark Silver accreditation, we are ideally placed to support areas including:

  • Designing and measuring the impact of transformation across care pathways on overall carbon emissions
  • Training and consultancy for developing social value strategies and plans that deliver measurable improvement for communities, the environment and the economy
  • Specialist accreditation of organisational and system social value through a quality mark and aligned operating measures and impacts.

Our teams can support and provide oversight of the drugs challenges process, including High Cost Drugs which includes unit pricing, ensure appropriate reporting to underpin decision making, and undertaking analysis and horizon scanning to improve value.

Our holistic PHM support is provided in six key areas:

  • Population definition - proven approaches to grouping and segmenting populations to develop a better understanding of healthcare needs
  • Outcomes measures - support in identifying the outcomes required and developing a framework for measurement
  • Data availability - using population health data to its best effect by linking and curating data in an accessible and user-friendly manner
  • Outcome driven financial mechanisms - enabling the transformation of care delivery via funding and contractual mechanisms that ensure risk and rewards are fairly distributed
  • System-wide culture - enabling systems to understand their current culture, identify and navigate barriers to effective PHM implementation (including the creation of value-based approaches and stewardship)
  • New models of care - multidisciplinary teams that support the entire transformational journey: opportunity development, system alignment, target operating models, implementation and evaluation.

We have experience of sourcing, collecting, linking and managing a broad range of datasets across the health and social care system.

As a Data Services for Commissioners Regional Office (DSCRO), we operate a secure and robust data environment meeting all Information Governance (IG) requirements and data sharing best practice.

 

We are proud to be part of the NHS and uphold its principles and core values in all that we do. Our ambition is to deliver tangible outcomes to the NHS by leveraging strategic partners and building strength-based alliances.

Download our Support for the Life Sciences sector brochure

Why Arden & GEM?

Our team comprises seasoned professionals with extensive expertise in all aspects of healthcare commissioning, management and front-line delivery.

Our extensive client base, service provision in multiple NHS market segments and deep understanding of NHS Commissioning and procurement means we are ideally positioned to support the life sciences sector in successfully integrating products

We are part of a CSU Collaborative that offers national access to a workforce of over 6,000 multidisciplinary experts, working with all forty-two ICBs, provide numerous clinical registries as well as drawing on specialist support from an established network of private sector organisations including AWS, Baringer, BT, Anaplan and Palantir and Health Economics Unit.

Our position within the NHS means we are uniquely placed to support NHS payors - many of whom we have existing relationships with, to understand the case for change, realise opportunities of new therapies across a pathway, visualise the solution and benefits, and support the embedding of changes to pathways with our experienced transformation specialists.

We aspire to provide an unrivalled service for the life sciences sector to work closer than ever with the NHS, as part of a values-based alliance.

CONTACT US

If you’d like to find out more about support for the Life Sciences sector please contact us here: